Medtronic - Minimally Invasive Therapies Group

Clinical trials sponsored by Medtronic - Minimally Invasive Therapies Group, explained in plain language.

Now part of Medtronic plc MDT NYSE

A division of Medtronic focused on surgical and minimally invasive technologies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Self-Gripping mesh aims to reduce hernia recurrence in High-Risk patients Results expected Sep 2026 (estimated)
New stapler aims to reduce leaks after colon surgery Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 6 Completed 8 Terminated 1

Mesh may prevent hernias after surgery, but trial cut short

Prevention Stopped early

This study tested a special mesh placed during abdominal surgery to prevent incisional hernias, which can occur in 10-50% of patients. The trial enrolled 32 adults undergoing elective midline laparotomy and tracked hernia development for 24 months using CT scans and exams. Howeve…

Sponsor: Medtronic - MITG • Aim: Prevention

Last updated Jun 27, 2026 08:01 UTC

Medtronic - Minimally Invasive Therapies Group

Upcoming readouts

Mesh may prevent hernias after surgery, but trial cut short